Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 25 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
241 24.0 months Metastatic breast cancer 4 Biologic therapy
City of Hope Comprehensive Cancer Center United States 11/2008
Treatment Details: Patients: This phase 2 study involved 14 women with metastatic breast cancer. The median age was 60.5, ranging from 37 to 89 years of age. Most (12) had previously received chemotherapy fo
 
242 24.0 months Castrate-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Washington University School of Medicine United States 9/2010
Treatment Details: Patients: This phase 2 study involved 79 men with castrate-resistant prostate cancer. The median age of the group was 69 years. Treatment: Patients in this study were given a combinati
 
243 24.0 months Stage III NSCLC 4 Chemotherapy
Radiation
University of North Carolina at Chapel Hill School of Medicine United States 10/2002
Treatment Details: Patients: This Phase I/II study involved 62 patients with stage IIIA (28 patients) or IIIB (34 patients) non-small-cell lung cancer. None of the patients had received prior chemotherapy or
 
244 24.0 months advanced ovarian cancer 4 Chemotherapy
Sarah Cannon Cancer Center United States 4/2005
Treatment Details: Patients: This Phase II study involved 52 women with stage II or IV ovarian cancer. The median age was 57. None of the patients had received first-line chemotherapy before the study. Tr
 
245 23.9 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Centre René Gauducheau France 4/2014
Treatment Details: Patients: This phase 3 study involved metastatic colorectal cancer patients who were separated into four different groups based on treatment and their genetic status of the KRAS gene. Grou
 
246 23.8 months Metastatic, castration-resistant prostate cancer 4 Biologic therapy
Chemotherapy
Hormone
British Columbia Cancer Agency Canada 8/2010
Treatment Details: Patients: In this study, male patients with metastatic castration-resistance prostate cancer were separated into two treatment groups, called arm A and arm B. Both arms consisted of 41 pat
 
247 23.7 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Hospital General Universitario Gregorio Marañón Spain 11/2010
Treatment Details: Patients: This study involved 46 patients with metastatic colorectal carcinoma who had not received prior chemotherapy. The median patient age was 64 years (range of 39-80), and 46% were m
 
248 23.7 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
New York University Cancer Institute United States 7/2008
Treatment Details: Patients: This study reports the findings of two studies, one involving 150 patients and the other involving 223 patients, with metastatic colorectal cancer. These patients ranged in age f
 
249 23.7 months Metastatic Breast Cancer 5 Biologic therapy
Chemotherapy
Institut Universitaire de Cancerologie Université Pierre et Marie Curie France 11/2014
Treatment Details: Patients: This phase 3 study involved HER2-negative metastatic breast cancer patients who were divided into two separate treatment groups. There were 94 patients in group A with a median ag
 
250 23.7 months Metastatic Colorectal Cancer 5 Biologic therapy
Chemotherapy
UCLA United States 6/2015
Treatment Details: Patients: This phase 2 study involved metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A had 96 patients with a median age of 61 years; 64% w
 
Page 25 of 187  | Previous Page  | Next Page